Scrip Symbol: ASTERDM
Target Entity: STS Holdings Limited
Type of Deal: Acquisition of minority stake through further investment transaction
Stake/Capacity: 22,727,584 equity shares acquired
Deal Value: USD 44,114,339 (Cash consideration)
Price per share: USD equivalent of BDT 273.45 per equity share (Face value: BDT 10)
Funding Source: Cash consideration (No details provided on funding structure or source)
Financial Impact: Not disclosed in the document. The acquisition is described as a "further investment transaction" but no specific financial impact on revenue, EBITDA, margins, or accretion/dilution is provided.
Timeline: Not applicable (as per Annexure A)
Strategic Rationale: The acquisition is in line with the Merger Framework Agreement executed on 29 November 2024. The document states the object is a "further investment transaction" but does not provide specific strategic rationale such as expansion, diversification, or synergy expectations.
Approval Status: The acquisition has been completed. It is part of a Scheme of Amalgamation between Quality Care India Limited and Aster DM Healthcare Limited approved by the Hon'ble National Company Law Tribunal, Hyderabad Bench on 19 June 2026.
Reference Regulation: SEBI Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Additional Target Company Details:
- Industry: Healthcare services and related training
- Incorporation Date: 28 August 1997
- Turnover History:
- 31 March 2024: BDT 7,777.02 Million
- 31 March 2025: BDT 8,902.8 Million
- 31 March 2026: BDT 10,534.24 Million
- Geographic Presence: Bangladesh exclusively
- Related Party Status: Not a related party transaction. Promoter/promoter group of Aster DM have no interest in STS Holdings Limited.
- Government Approvals: Not required